Last reviewed · How we verify
Corticosteroid and 1%lidocain
At a glance
| Generic name | Corticosteroid and 1%lidocain |
|---|---|
| Sponsor | University of California, San Francisco |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Percutaneous Electrical Nerve Stimulation As Alternative To Nerve Blocks In Anesthesia, Pain Medicine And Rehabilitation Of Nonspecific Chronic Pain (PHASE4)
- Frozen Shoulder and Hormone Replacement Therapy (PHASE4)
- Treatment of Calcific Tendinitis of the Rotator Cuff (NA)
- Advice vs Advice + Exercise vs Advice + Exercise + Injection for Individuals With Plantar Fasciopathy (NA)
- Hyaluronic Acid Hydro-dissection Use in Idiopathic Carpal Tunnel Syndrome Guided by Ultrasonic Study (PHASE1)
- Heavy-slow Resistance Training and Ultrasound-guided Corticosteroid Injection in Plantar Fasciopathy (NA)
- Corticosteroid and Lidocain Injections for Tennis Elbow (NA)
- Exercise and Steroid in Knee Osteoarthritis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Corticosteroid and 1%lidocain CI brief — competitive landscape report
- Corticosteroid and 1%lidocain updates RSS · CI watch RSS
- University of California, San Francisco portfolio CI